imal Targeting Agents: Choosing Between Antibodies & Ligands to Maximize Efficacy & Overcome Delivery Challenges
- Analyzing differential cellular processing of antibodies versus ligands to guide therapeutic strategy
- Comparing biodistribution of antibodies versus ligands to optimize target delivery
- Identifying opportunities for synergistic efficacy to enhance treatment outcomes